BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Operating Expenses (2018 - 2026)

BiomX's (PHGE) quarterly Operating Expenses came in at $5.4 million in Q2 2026, down 27.58% year-over-year from $7.4 million in Q2 2025, and up 315.35% quarter-over-quarter from $1.3 million in Q1 2026.

Analysis

BiomX (PHGE) Operating Expenses (2018 - 2026) Analysis & Trends

BiomX has disclosed Operating Expenses across 9 years of filings, most recently posting $5.4 million for Q2 2026.

  • In Q2 2026, Operating Expenses fell 27.58% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $12.0 million (down 45.74% YoY), while the FY2025 annual figure was $30.9 million, down 17.5% from the prior year.
  • Operating Expenses came in at $5.4 million for Q2 2026 at BiomX, up from $1.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $9.7 million in Q2 2024 to a low of -$2.4 million in Q3 2024.
  • Average Operating Expenses over 5 years is $5.3 million, with a median of $6.4 million recorded in 2022.
  • The largest YoY upside for Operating Expenses was 78.34% in 2024 against a maximum downside of 130.96% in 2024.
  • Over 5 years, Operating Expenses stood at $5.2 million in 2022, then gained by 1.78% to $5.3 million in 2023, then surged by 78.34% to $9.4 million in 2024, then retreated by 23.47% to $7.2 million in 2025, then declined by 25.18% to $5.4 million in 2026.
  • Per Business Quant data, the three most recent Operating Expenses figures were $5.4 million in Q2 2026, $1.3 million in Q1 2026, and $7.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 367.83 Mn
10 BiomX 17.33 Mn 16.75 Mn 97,000.00 5.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.38 Mn
Mar 31, 2026 1.30 Mn
Dec 31, 2025 7.20 Mn
Sep 30, 2025 -1.84 Mn
Jun 30, 2025 7.43 Mn
Mar 31, 2025 7.76 Mn
Dec 31, 2024 9.40 Mn
Sep 30, 2024 -2.41 Mn
Jun 30, 2024 9.73 Mn
Dec 31, 2023 5.27 Mn
Sep 30, 2023 7.80 Mn
Jun 30, 2023 6.26 Mn
Mar 31, 2023 565,000.00
Dec 31, 2022 5.18 Mn
Sep 30, 2022 6.43 Mn
Jun 30, 2022 7.14 Mn
Mar 31, 2022 7.41 Mn
Dec 31, 2021 14.03 Mn
Sep 30, 2021 9.90 Mn
Jun 30, 2021 6.92 Mn